Zentrela Inc.

Zentrela is a neurotechnology company advancing how non-medical product effects are objectively measured.

We use AI-driven EEG analysis to rapidly and affordably quantify temporary changes in mental states such as relaxation, energy, mood, stress, anxiety, sleepiness, mental clarity, and psychoactive effects, without relying solely on subjective questionnaires or costly clinical trials.

Our proprietary platform, Cognalyzer®, translates raw brainwave data into standardized, interpretable metrics that help innovative companies validate product efficacy, optimize formulations, and strengthen scientific credibility.

Zentrela works with brands, ingredient suppliers, researchers, and institutions across wellness, nutraceuticals, cannabis, functional CPG, and emerging health categories to generate IRB-approved human evidence that supports product development, white papers, and peer-reviewed publications.